about
Mesenchymal stem cell therapy for liver fibrosisEvolving therapies for liver fibrosis.Concise review: clinical programs of stem cell therapies for liver and pancreasVirus-related liver cirrhosis: molecular basis and therapeutic options.Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators.Exosomes from mesenchymal stem cells induce the conversion of hepatocytes into progenitor oval cells.Therapeutic potential of dental stem cells.Alcoholic liver disease: treatmentAcute-on-chronic Liver Failure.Tumor necrosis factor-inducible gene 6 promotes liver regeneration in mice with acute liver injury.Antioxidant treatment enhances human mesenchymal stem cell anti-stress ability and therapeutic efficacy in an acute liver failure model.Natural Killer Cells-Produced IFN-γ Improves Bone Marrow-Derived Hepatocytes Regeneration in Murine Liver Failure Model.Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials.Bone marrow stem-cell therapy for genetic and chronic liver diseases.Effect of Microenvironment on Differentiation of Human Umbilical Cord Mesenchymal Stem Cells into Hepatocytes In Vitro and In Vivo.Interleukin-6 secreted by bipotential murine oval liver stem cells induces apoptosis of activated hepatic stellate cells by activating NF-κB-inducible nitric oxide synthase signaling.Molecular Imaging of Stem Cell Transplantation for Liver Diseases: Monitoring, Clinical Translation, and Theranostics.Progress in stem cell-based therapy for liver disease.Liver Regeneration: Analysis of the Main Relevant Signaling Molecules.Transplantation of mesenchymal stem cells expressing TIMP-1-shRNA improves hepatic fibrosis in CCl₄-treated rats.Treatment options for alcoholic and non-alcoholic fatty liver disease: A review.Precise Regulation of miR-210 Is Critical for the Cellular Homeostasis Maintenance and Transplantation Efficacy Enhancement of Mesenchymal Stem Cells in Acute Liver Failure Therapy.Heterogenic transplantation of bone marrow-derived rhesus macaque mesenchymal stem cells ameliorates liver fibrosis induced by carbon tetrachloride in mouse.Stem Cell Therapies for Treatment of Liver Disease.Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway.A pooled analysis of mesenchymal stem cell-based therapy for liver disease.Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis.Melatonin promotes hepatic differentiation of human dental pulp stem cells: clinical implications for the prevention of liver fibrosis.Umbilical cord blood stem cells transplantation as an adjunctive treatment strategy for liver cirrhosis in Chinese population: a meta-analysis of effectiveness and safety.
P2860
Q26782128-140D3673-A282-4E89-962A-16B70DC4C6D1Q30539166-D6757075-4932-432C-BE95-C6FF4AB9E8E9Q30555472-935BA23C-934F-4CE5-A9D2-BD1CF3CEFB95Q33718267-74C51119-623B-45A4-983A-93193C3EC592Q33722100-0B812884-8696-4D2E-8F60-4F674FAF556DQ33722788-E5E7348F-FF02-4112-9A83-DFC384240BA6Q33772243-B042CC2F-B1BA-4E3F-8DE2-7D71A8D6F1C8Q34255479-13E29956-884A-4B8D-BD7B-740B25459C5AQ34542736-DD69DB10-704B-462F-82E7-E20038A565CDQ35409945-61C070F3-97C6-48C8-AF32-6C0589607662Q35701725-85562804-8110-4FB8-95E7-5DAEA8DE3CB9Q36033943-C8ECBAE2-14F6-4244-A3EB-0496EEDC4909Q38414766-25D8573E-9775-4794-B7A0-027CB8F5CBC8Q38552426-C9783721-20DC-48CB-9903-4F69538BED65Q38606215-C3172CB2-8AE0-4215-B1FF-C67F7847007EQ38717345-293B4CD2-034D-48A0-AA47-90CBAD82A7E9Q38772557-7D3FFA6F-0137-460B-AE97-D88E16153AE6Q38836460-D550CC7A-23D4-49EF-9BEC-9A742A1162E1Q41693137-435FD85A-017A-457D-8E43-9C369E5BC8C5Q42155791-9611E6D0-D7D9-4CC1-8D2F-C8D36CB9CF14Q42695159-560D14FE-FBF6-48B3-BEA7-F450351E8B10Q45958618-57E3A926-9F16-40C7-B11D-3DDE56213126Q49873752-4BECDDCA-737B-4D55-B631-3723ED2CEB86Q51032622-5F0EF136-253B-45D8-A583-9EA07B298A7DQ51144706-040B749A-FC72-445E-A706-43403AA163F5Q52644305-C2559892-828C-44B3-96D2-1CB6EECF09FEQ53072949-B85E909A-0448-47A3-B208-9F9B339A6FC3Q54307415-E0F727FD-2924-4502-B961-7118A06FD14FQ55041659-38CB65DB-21D1-43AB-B274-9362DDBE0CD0
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Stem cell therapies for liver failure and cirrhosis
@ast
Stem cell therapies for liver failure and cirrhosis
@en
Stem cell therapies for liver failure and cirrhosis
@nl
type
label
Stem cell therapies for liver failure and cirrhosis
@ast
Stem cell therapies for liver failure and cirrhosis
@en
Stem cell therapies for liver failure and cirrhosis
@nl
prefLabel
Stem cell therapies for liver failure and cirrhosis
@ast
Stem cell therapies for liver failure and cirrhosis
@en
Stem cell therapies for liver failure and cirrhosis
@nl
P1476
Stem cell therapies for liver failure and cirrhosis
@en
P2093
Fu-Sheng Wang
Zheng Zhang
P356
10.1016/J.JHEP.2013.01.018
P407
P577
2013-07-01T00:00:00Z